Literature DB >> 19407337

Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.

Yue J Cui1, Lauren M Aleksunes, Yuji Tanaka, Michael J Goedken, Curtis D Klaassen.   

Abstract

Alpha-naphthyl isothiocyanate (ANIT) is a hepatotoxicant that produces acute intrahepatic cholestasis in rodents. Farnesoid X receptor (FXR) and pregnane X receptor (PXR) are two major bile acid sensors in liver. The purpose of this study was to characterize the regulation of hepatic transporters by FXR and PXR during ANIT-induced liver injury. Wild-type, FXR-null, and PXR-null mice were administered ANIT (75 mg/kg, po) and evaluated 48 h later for hepatotoxicity and messenger RNA (mRNA) expression of basolateral uptake (sodium taurocholate-cotransporting polypeptide, organic anion transporting polypeptide [Oatp] 1a1, Oatp1a4, Oatp1b2) and efflux transporters (organic solute transporter [Ost] alpha, Ostbeta, multidrug resistance-associated protein [Mrp] 3, Mrp4), as well as canalicular transporters (bile salt export pump [Bsep], Mrp2, multidrug resistance protein 2 [Mdr2], ATPase, class I, type 8B, member 1 [Atp8b1]). Livers from wild-type and PXR-null mice had comparable multifocal necrosis 48 h after ANIT. However, ANIT-treated FXR-null mice have fewer and smaller necrotic foci than wild-type mice but had scattered single-cell hepatocyte necrosis throughout the liver. Serum alanine transaminase, alkaline phosphatase (ALP), and direct bilirubin were increased in all genotypes, with higher ALP levels in FXR-null mice. Serum and liver unconjugated bile acids were higher in ANIT-treated FXR-null mice than the other two genotypes. ANIT induced mRNA expression of Mdr2, Bsep, and Atp8b1 in wild-type and PXR-null mice but failed to upregulate these genes in FXR-null mice. mRNA expression of uptake transporters declined in livers of all genotypes following ANIT treatment. ANIT increased Ostbeta and Mrp3 mRNA in livers of wild-type and PXR-null mice but did not alter Ostbeta mRNA in FXR-null mice. In conclusion, FXR deficiency enhances susceptibility of mice to ANIT-induced liver injury, likely a result of impaired induction of hepatobiliary efflux transporters and subsequent hepatic accumulation of unconjugated bile acids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407337      PMCID: PMC2696329          DOI: 10.1093/toxsci/kfp094

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  46 in total

1.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.

Authors:  J L Staudinger; B Goodwin; S A Jones; D Hawkins-Brown; K I MacKenzie; A LaTour; Y Liu; C D Klaassen; K K Brown; J Reinhard; T M Willson; B H Koller; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.

Authors:  Juan-Felipe Lucena; J Ignacio Herrero; Jorge Quiroga; Bruno Sangro; Jesus Garcia-Foncillas; Natalia Zabalegui; Josu Sola; Maite Herraiz; Juan F Medina; Jesus Prieto
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

3.  Role of MRP2 and GSH in intrahepatic cycling of toxins.

Authors:  C G Dietrich; R Ottenhoff; D R de Waart; R P Oude Elferink
Journal:  Toxicology       Date:  2001-10-05       Impact factor: 4.221

Review 4.  The pathophysiology of cholestasis with special reference to primary biliary cirrhosis.

Authors:  P L Jansen
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  2000-08

Review 5.  Bile salt transporters: molecular characterization, function, and regulation.

Authors:  Michael Trauner; James L Boyer
Journal:  Physiol Rev       Date:  2003-04       Impact factor: 37.312

6.  Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.

Authors:  C Funk; C Ponelle; G Scheuermann; M Pantze
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

7.  Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump.

Authors:  Jacqueline R M Plass; Olaf Mol; Janette Heegsma; Mariska Geuken; Klaas Nico Faber; Peter L M Jansen; Michael Müller
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 8.  Bile acid regulation of gene expression: roles of nuclear hormone receptors.

Authors:  John Y L Chiang
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

9.  Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome.

Authors:  Kenkichi Hashimoto; Takeshi Uchiumi; Toshikazu Konno; Takuya Ebihara; Takanori Nakamura; Morimasa Wada; Shotaro Sakisaka; Fumio Maniwa; Teruo Amachi; Kazumitsu Ueda; Michihiko Kuwano
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 10.  Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.

Authors:  C Colombo; L Okolicsanyi; M Strazzabosco
Journal:  Dig Liver Dis       Date:  2000-03       Impact factor: 4.088

View more
  40 in total

Review 1.  Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.

Authors:  Paul A Dawson; Melissa L Hubbert; Anuradha Rao
Journal:  Biochim Biophys Acta       Date:  2010-06-09

Review 2.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

3.  Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice.

Authors:  Felcy Pavithra Selwyn; Sunny Lihua Cheng; Theo K Bammler; Bhagwat Prasad; Marc Vrana; Curtis Klaassen; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2015-06-01       Impact factor: 4.849

4.  Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway.

Authors:  Shogo Takahashi; Naoki Tanaka; Srujana Golla; Tatsuki Fukami; Kristopher W Krausz; Marianne A Polunas; Blair C Weig; Yusuke Masuo; Cen Xie; Changtao Jiang; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2017-08-01       Impact factor: 4.849

5.  Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses.

Authors:  Qiao-Ling Yang; Fan Yang; Jun-Ting Gong; Xiao-Wen Tang; Guang-Yun Wang; Zheng-Tao Wang; Li Yang
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

6.  18β-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1/FXR signaling pathway.

Authors:  Shou-Yan Wu; Shi-Chao Cui; Le Wang; Yi-Ting Zhang; Xiao-Xia Yan; Heng-Lei Lu; Guo-Zhen Xing; Jin Ren; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2018-07-30       Impact factor: 6.150

7.  Individual bile acids have differential effects on bile acid signaling in mice.

Authors:  Peizhen Song; Cheryl E Rockwell; Julia Yue Cui; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-09       Impact factor: 4.219

Review 8.  Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.

Authors:  X Chu; K Korzekwa; R Elsby; K Fenner; A Galetin; Y Lai; P Matsson; A Moss; S Nagar; G R Rosania; J P F Bai; J W Polli; Y Sugiyama; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2013-04-10       Impact factor: 6.875

9.  Exposure to the synthetic FXR agonist GW4064 causes alterations in gene expression and sublethal hepatotoxicity in eleutheroembryo medaka (Oryzias latipes).

Authors:  Deanna L Howarth; Sheran H W Law; J McHugh Law; J A Mondon; Seth W Kullman; David E Hinton
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-03       Impact factor: 4.219

10.  Pregnancy represses induction of efflux transporters in livers of type I diabetic mice.

Authors:  Lauren M Aleksunes; Jialin Xu; Eugenia Lin; Xia Wen; Michael J Goedken; Angela L Slitt
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.